Clinical analysis of 670 cases in two trials of the European organization for the research and treatment of cancer lymphoma cooperative group subtyped according to the revised European-American classification of lymphoid neoplasms: A comparison with the working formulation

Blood

Volumn 87, Issue 10, 1996, Pages 4358-4367

  Pittaluga, S ^a   Bijnens, L ^b   Teodorovic, I ^b   Hagenbeek, A ^b   Meerwaldt, J H ^b   Somers, R ^b   Thomas, J ^b   Noordijk, E M ^b   De Wolf Peeters, C ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; BLEOMYCIN; BONE MARROW; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; HUMANS; IMMUNOPHENOTYPING; INTERFERON ALFA-2A; LIFE TABLES; LYMPHOMA, NON-HODGKIN; MECHLORETHAMINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; VINCRISTINE;

EID: 0029990274     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4358.bloodjournal87104358     Document Type: Review

References (24)

1. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 49:2112, 1982
2. Lennert K, Feller AC: Histopathology of Non-Hodgkin's Lymphomas (Based on the Updated Kiel Classification). Berlin, Germany, Springer-Verlag, 1992
3. Longo DL, Wilson W: Follicular Lymphomas, in Magrath IT (ed): The Non-Hodgkin's Lymphomas, vol 19. Baltimore, MD, Williams & Wilkins, 1990, p 293
4. Berger F, Felman P, Sonet A, Salles G, Bastion Y, Bryon PA, Coiffier B: Nonfollicular small B-cells lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829, 1994
5. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study. Blood 84:1075, 1995
6. Pittaluga S, Verhoef G, Criel A, Maes A, Nuyts J, Boogaerts M, De Wolf Peeters C: Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 18:179, 1995
7. Norton AJ, Matthews J, Pappa V, Shamash J, Love S, Rohatiner AZS: Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249, 1995
8. Mann RB, Berard CW: Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method. Hematol Oncol 1:187, 1983
9. Nathwani BN, Metter GE, Miller TP, Burke JS, Mann RB, Barcos M, Kjeldsberg CR, Dixon DO, Winberg CD, Whitcomb CC, Jones SE: What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 68:837, 1986
10. Harris NL, Jaffe E, Stein H, Banks PM, Chan JCK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Pins MA, Ralfkiaer E, Warnke RA: A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
11. Somers R, Carde P, Thomas J, Tirelli U, Keuning JJ, Bron D, Delmer A, de Bock R, De Wolf-Peeters, van Glabbeke M, Duez N: EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, IV intermediate- and high-grade lymphoma. Ann Oncol 5:S85, 1994 (suppl 2)
12. Teodorovic I, Pittaluga S, Kluin-Nelemans H, Meerwaldt JH, Hagenbeek A, van Glabbeke M, Somers R, Bijnens L, Noordijk EM, De Wolf-Peeters C: Efficacy of four different regimens in 64 mantle cell lymphoma cases - Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes - EORTC Lymphoma Cooperative Group. J Clin Oncol 13:2819, 1995
13. Jaffe ES, Raffeld M, Medeiros LJ: Histopathological subtypes of indolent lymphomas: Caricatures of the mature B-cell system. Semin Oncol 20:3, 1993 (suppl 5)
14. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27:335, 1985
15. Kaplan EL, Meier P: Non-parametric estimation of the incomplete observations. J Am Stat Assoc 53:457, 1958
16. Slud EV, Byar D, Green SB: A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data. Biometrics 40:587, 1984
17. Tarone RE: Tests for trend in life table analysis. Biometrics 62:679, 1975
18. Harris NL: Lymphoma 1987. An interim approach to diagnosis and classification. Pathol Annual 22:1, 1987
19. Jaffe ES, Raffeld M, Medeiros LJ, Stetler-Stevenson M: An overview of the classification of Non-Hodgkin's lymphomas: An integration of morphological and phenotypical concepts. Cancer Res 52:5447s, 1992
20. Martin A, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM, Bierman PJ, Bast MA, Daley DT, Armitage JO: Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85:3671, 1995
21. Ezdinli EZ, Costello WG, Kucuk O, Berard CW: Effect of the degree of nodularity on the survival of patients with nodular lymphomas. J Clin Oncol 5:413, 1987
22. Glick JH, Barnes JM, Ezdinli EZ, Berard CW, Orlow EL, Bennet JM: Nodular mixed lymphoma: Results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 58:920, 1981
23. Bastion Y, Berger F, Bryon PA, Felman M, Coiffier B: Follicular lymphomas: Assessement of prognostic factors in 127 patients followed for 10 years. Ann Oncol 2:123, 1991 (suppl 2)
24. Watanabe S, Nakajima T, Shimosato Y, Shimoyama M, Minato K: T-cell malignancies: Subclassification and interrelationship. Jpn J Clin Oncol 9:423, 1979 (suppl)